According to the Mayo Clinic, hip replacement surgery is generally safe. But as with any surgery, complications can occur. Some complications are serious. But fortunately, most can be treated successfully.
Potential complications from hip replacement include:
A U.S. Food and Drug Administration advisory panel has voted against approving Johnson & Johnson’s blood thinner Xarelto for prevention of blood clots in people with acute coronary syndrome.
According to U.S. News and World Report, the 6-to-4 decision came as a surprise because an FDA briefing document filed Monday in advance of the ruling gave the drug a favorable assessment.
But panel members reportedly said company studies did not provide enough ...
continue reading...In a Motley Fool article for MSNBC, Sara Wright recommends against investing in manufacturers of dangerous medical devices that made it onto the market through a regulatory loophole.
“I cannot see clear to investing my money in companies that do not take the safety and efficacy of their products more seriously,” she writes.
Among the companies she spotlights are Johnson & Johnson, owner of a subsidiary that made read more.... --> continue reading...
Consumers Union, the policy and advocacy arm of Consumer Reports, has placed a full-page print ad in Washington, D.C.-based publication Politico, calling on Congress to close a loophole that allows dangerous devices to make it on the market without clinical testing.
The ad is running as the U.S. Senate prepares to vote on a bill this week to reauthorize the statute governing medical device oversight.
It specifically makes reference to two medical ...
continue reading...
Lawyers representing Pennsylvania and Johnson & Johnson both argued their side before a panel of seven Commonwealth Court justices on Wednesday, in a case involving allegations that Johnson & Johnson defrauded Pennsylvania out of millions of taxpayer dollars.
At issue is whether the company misled Medicaid officials about the risks of antipsychotic drug Risperdal and marketed it for unapproved uses, duping the state into improperly paying millions more for the drug ...
continue reading...
Commonwealth Court judges are scheduled to hear an appeal of the decision dismissing Pennsylvania’s 2008 lawsuit against Johnson & Johnson. The company is accused of fraudulently profiting from sales of the antipsychotic drug Risperdal through the Medicaid program.
According to an article in the Philadelphia Inquirer, Pennsylvania previously filed a lawsuit alleging that Johnson & Johnson tricked the state into paying millions more for the drug than it should have. But ...
continue reading...
